MedPath

An Evaluation of the Effect of the Erchonia Corporation Violet Zerona® Z6 for Body Contouring

Not Applicable
Completed
Conditions
Circumference Reduction
Registration Number
NCT05674292
Lead Sponsor
Erchonia Corporation
Brief Summary

The purpose of this clinical study is to determine the effectiveness of the Erchonia® Violet Zerona Z6 (manufactured by Erchonia Corporation (the Company), an over-the-counter (OTC) laser device, in providing noninvasive body circumference reduction.

Detailed Description

The clinical study is an open-label non-inferiority design to evaluate the efficacy of the Erchonia® Violet Zerona Z6, an over-the-counter (OTC) laser device, in providing noninvasive circumference reduction. The clinical study protocol is based on the protocol for the clinical study whose results were submitted in support of clearance of the predicate device, the Erchonia® Zerona® Z6 OTC.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • BMI is 30 or less
  • 18 years of age or older
Exclusion Criteria
  • Pregnant
  • Open wounds (sores, cuts, ulcers, etc.)
  • Individuals with or being treated for any cancerous growth

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Combined Circumference Reduction in Inches of the Waist, Hips, and Bilateral Thighs2 weeks

Mean change in total combined circumference inches of the waist, hips and bilateral thighs from baseline to endpoint evaluation.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Tracey Hishon

🇺🇸

Bloomfield Hills, Michigan, United States

Jamie Thayer

🇺🇸

Marquette, Michigan, United States

Tracey Hishon
🇺🇸Bloomfield Hills, Michigan, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.